We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
Sekisui Diagnostics

Download Mobile App




In Other News

Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Waters Corporation and Quest Diagnostics have formed a collaboration to broaden access to the FDA-cleared Onclarity Self-Collection Kit. Read more
22 Oct 2026 | Industry
Image: AlzoSure Predict is designed to help clinicians assess the likelihood of Alzheimer’s disease progression in patients with mild cognitive impairment. (Photo courtesy of Diadem)

Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch

A new blood test predicts Alzheimer’s progression up to six years before symptoms by measuring a disease-related protein marker. Read more
22 Oct 2026 | Industry
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Revvity has launched Signals LabGistics, an AI-first scientific workflow orchestration solution from its Revvity Signals Software business. Read more
21 Oct 2026 | Technology
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

An antibody-profiling approach detects inflammatory bowel disease signatures up to 10 years before diagnosis. Read more
21 Oct 2026 | Immunology
Image: Biodesix is developing a radiomics-based lung nodule risk assessment test to complement its Nodify Lung portfolio (Photo courtesy of Biodesix)

Multimodal Platform to Combine Blood and Imaging Biomarkers for Lung Nodule Assessment

A new AI-enabled multimodal test combines blood and CT radiomics to improve lung nodule risk assessment. Read more
21 Oct 2026 | Clinical Chem.
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

An AI system automates QC, tumor detection, mitotic counts, and cellularity to speed pathology and cut failed molecular tests Read more
21 Oct 2026 | Pathology
Image

GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026

GeneDx is presenting 27 scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting. Read more
21 Oct 2026 | Molecular Diagnostics
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic has signed a definitive agreement to acquire precision oncology company Reveal Genomics. Read more
20 Oct 2026 | Industry
Image Credit: iStock

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

A new in-house genetic testing model cuts diagnosis of pediatric immune disorders from 12 months to as little as two weeks. Read more
20 Oct 2026 | Molecular Diagnostics
Image: The study analyzed saliva samples from people undergoing treatment for OCD (Image Credit: Adobe Stock)

Study Links Saliva-Based Epigenetic Signals to OCD Treatment Outcomes

New findings link DNA methylation markers to OCD psychotherapy response, supporting personalized treatment. Read more
20 Oct 2026 | Clinical Chem.
Image: The newly released RepX uses Electronic Genome Mapping (EGM) data generated on the OhmX Platform (Photo courtesy of Nabsys)

Genomic Tool Supports Analysis of Repeat Expansions Linked to Inherited Disorders

A newly launched analysis pipeline now uses electronic genome mapping data to investigate disease-associated repeat expansions Read more
20 Oct 2026 | BioResearch
Image: The definitive agreement covers Myriad Genetics’ Prenatal Health testing business, including the Prequel, Foresight, SneakPeek, and FirstGene tests. (Photo courtesy of Myriad Genetics)

Myriad Genetics to Sell Prenatal Testing Portfolio to Labcorp

Myriad Genetics has entered into a definitive agreement to sell its Prenatal Health testing business to Labcorp for $210 million. Read more
20 Oct 2026 | Industry
Image Credit: iStock

Managed Care Report Examines Barriers to Breast Cancer Biomarker Testing

A new analysis examines uncertainty around biomarker testing and managed care for advanced breast cancer with ESR1 mutations. Read more
20 Oct 2026 | Industry

Channels

Clinical Chemistry

view channel
Multimodal Clinical Data Models Predict Cachexia Risk Across Cancers
Study Evaluates Alzheimer’s Blood Biomarker Across Racial and Ethnic Groups
Blood Protein May Help Identify Treatment-Resistant Psychosis
Image: A new pilot rapid test for syphilis from a team led by Penn State researchers integrates two blood tests into one and detects bacteria at very low levels to detect the disease in its earliest stages. (Photo courtesy of Pan Research Lab / Penn State)

New One-Step Syphilis Test Could Enable Earlier Detection and Faster Treatment

Syphilis can be difficult to diagnose because its symptoms may resemble other diseases and appear and disappear without treatment. Undetected infection can continue causing harm, spread to partners and... Read more

Molecular Diagnostics

view channel
RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer
Modeling Study Shows Blood-Based CRC Screening Could Prevent More Deaths Than Stool...
AI Tool Classifies Pathogenic Variants in Severe Childhood Epilepsy
Image Credit: iStock

Clinical Trial Evaluates Liquid Biopsy for Early-Stage Breast Cancer Detection

Breast cancer screening relies primarily on mammography, but abnormal findings can lead to additional imaging, biopsy, or repeat imaging after six months, creating anxiety and potentially delaying treatment... Read more

Hematology

view channel
Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Traum...
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Image: The recommendations include extended molecular testing at diagnosis to identify high-risk mutations and guide care. (Image Credit: Adobe Stock)

New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis

Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read more

Immunology

view channel
Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth...
Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Chil...
FDA Approval Adds Automated Testing Option for Parvovirus B19 Serology
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Microbiology

view channel
Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis
Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms
Study Finds Distinct Malaria Parasites Linked to Sickle Cell Trait Protection
Image Credit: 123RF

Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response

The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read more

Pathology

view channel
Updated Digital Pathology Platform Expands AI Integration for Cancer Diagnosis
AI Histopathology Tool Distinguishes Ewing Sarcoma for Diagnosis
Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Image: TissueCypher analyzes protein biomarkers and tissue architecture in biopsy samples to estimate five-year risk of progression to high-grade dysplasia or esophageal adenocarcinoma. (Photo courtesy of Castle Biosciences)

Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings

Barrett’s esophagus is a precancerous condition associated with increased risk of esophageal adenocarcinoma. Routine endoscopic biopsy findings guide surveillance and therapy, but histopathology may not... Read more

Technology

view channel
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detectio...
New Automation Workflow Streamlines NGS Library Preparation for High-Volume Labs
ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Collaboration Advances Genomic Instability Biomarker for Prostate Cancer
Labcorp Acquisition to Strengthen Specialty Testing and Prostate Cancer Assessme...
Expanded Partnership Scales AI-Powered Digital Pathology for Oncology
Image: Latest trends show that cancer diagnosis is evolving beyond a process focused mainly on medical imaging and microscopic tissue examination toward a more layered approach that incorporates molecular and genomic testing, liquid biopsy, digital pathology, and AI (Image Credit: iStock)

Expanding Screening and Biomarker Testing Drive Cancer Diagnostics Market Growth

Cancer diagnostics encompasses imaging, tissue pathology, laboratory testing, and molecular technologies used to detect, confirm, characterize, and monitor cancer. The global cancer diagnostics market... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
Industry
BioResearch
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
ADLM WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica

 

ADLM Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE